In addition, for triple-negative breast cancer, studies have demonstrated the effectiveness of adjuvanted survivin peptide particulate vaccine in the mouse 4T1 tumor line model of triple-negative breast cancer. Here, BIRC5 is linked to triple-negative breast carcinoma.